- News & Events
Prof. Jerry S. Wolinsky is an Interim Chair, Dept. of Neurology; Bartels Family and Opal C. Rankin Prof. of Neurology, Dept. of Neurology; Director, MRI Analysis Center; Director, Multiple Sclerosis Research Group and the Magnetic Resonance Imaging Analysis Center, The University of Texas Medical School at Houston. Certified by the National Board of Medical Examiners and the American Board of Psychiatry and Neurology, Dr. Wolinsky’s primary clinical interests are multiple sclerosis and related demyelinating disorders and magnetic resonance imaging. Dr. Wolinsky has vast experience in leading clinical trials, including Copaxone clinical trials. He is recognized in The Best Doctors in America and America’s Top Doctors lists, and has authored more than 300 publications. Dr. Wolinsky received his medical degree from the University of Illinois in 1969 and completed his residency in clinical neurology and a fellowship in experimental neuropathology at the University of California, San Francisco. He later joined the faculty of the Schools of Medicine and Hygiene and Public Health at Johns Hopkins University.
Dr. Ben-Zion Weiner was Head of Global Research and Development at Teva Pharmaceutical Industries Ltd. for over three decades, including as Chief R&D Officer and as a member of the Teva Executive Committee. He directly oversaw all pharmaceutical R&D and the development and regulatory approval of an innovative branded product pipeline. Dr. Weiner was also responsible for the development of hundreds of generic products for the US, European and other markets. In parallel, he has been responsible for the development and regulatory approval of Teva’s innovative product portfolio. Dr. Weiner has twice been the recipient of the Rothschild Prize for Industrial Innovation, including for the development and commercialization of Copaxone for the treatment of Multiple Sclerosis. Dr. Weiner has been involved in multiple pharmaceutical activities since retiring from Teva and currently serves on the Mesoblast Board of Directors as an independent non-executive Director. He received a B.Sc. degree in General Chemistry and Biochemistry and an M.Sc. degree in Organic Chemistry, graduating with distinction for both degrees from the Hebrew University, Jerusalem. He received his Ph.D. degree in Chemistry at the Hebrew University, Jerusalem, and conducted his post-doctorate research at Schering-Plough Corporation in the United States.
Prof. Ben-Hur is the chairman of the department of neurology at Hadassah University Medical Center, Jerusalem. Prof. Ben-Hur’s research projects focus on regenerative medicine and cell therapy for the brain, demyelination and remyelination in the central nervous system, neuroimmunology of multiple sclerosis and experimental autoimmune encephalomyelitis. He earned his MD and PhD degrees from the Hebrew University. Prof. Ben-Hur is a professor of neurology and holds the Israel S. Wechsler Chair in neurology at the Hebrew University Hadassah Medical School.
Prof. Naparstek is a professor of internal medicine at the Hebrew University, Jerusalem, and is the incumbent of the Leifferman Chair in Rheumatology. Prof. Naparstek served as the chairman of medicine in the Hadassah University Hospital for 13 years, as well as the senior deputy director general for research & academic affairs at the Hadassah University Hospital. Prof. Naparstek is the founder and chief scientist of both Verto Medical Ltd. and Protab Therapeutics Ltd., both biotechnological companies, and serves as a consultant and scientific advisory board member in other medical-biotechnology companies. Prof. Naparstek is the recipient of national and international awards, including the 2011 Elkeles Prize in Medicine, and has authored more than 100 publications and chapters in books, as well as many patents in the field of autoimmune inflammatory diseases. Prof. Naparstek is a graduate of the Hadassah-Hebrew University Medical School in Jerusalem, Israel, is certified in Internal Medicine, Rheumatology and Clinical Immunology and Allergy and has been a research fellow and a visiting professor at the Weizmann Institute of Science, Tuft’s University, the National Institute of Health and Stanford University.